Skip to main content

Table 2 Representative percentages of HCT11 p53-/- cells in the different cell cycle phases following Nutlin-3 or Etoposide treatment as described in Additional file 2.

From: A p53-independent role for the MDM2 antagonist Nutlin-3 in DNA damage response initiation

p53-/- subG1 G1 S G2/M
Control 3.2 56.3 14.8 25.7
Nut 10 nM 5.7 19.5 25.3 49.5
Nut 15 nM 7.7 18.6 22.7 51.0
Nut 20 nM 7.2 18.3 22.7 51.8
Etoposide 10.2 13.7 19.1 57.0
\